# HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
> **ANDA205731** · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS US · Approved 2017-02-15
## Drug
- **FDA Application Number:** ANDA205731
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE
- **Generic name:** Homatropine Methylbromide
- **Active ingredients:** HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE
- **Dosage form:** SYRUP
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** PADAGIS US
- **First approval:** 2017-02-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205731)
---
*MORVS · CC0 1.0*